iSBTc

Related by string. * * Cancer iSBTc *

Related by context. Frequent words. (Click for all words.) 59 Keystone Symposia 59 EORTC 59 AASLD 59 SABCS 59 ASCO Annual Meeting 59 EORTC NCI AACR 58 EASL 58 AAPM 57 IADR 57 EASD 57 Digestive Disease Week DDW 57 CROI 57 BIO InvestorForum 57 Breast Cancer Symposium 57 Poster Presentation 57 ESMO 57 ARVO 57 ASCRS 57 AACR NCI EORTC 56 ESHRE 56 J Clin Oncol 55 Transcatheter Cardiovascular Therapeutics TCT 55 Oral Presentation 55 Lung Transplantation 55 Oncologic Drugs Advisory 54 Cambridge Healthtech Institute 54 RTOG 54 EORTC NCI AACR Symposium 54 Cardiology ESC 54 Clinical Oncology Annual Meeting 54 Poster Session 54 Pediatric Academic Societies 54 Molecular Cancer 53 Arch Neurol 53 Autoimmunity 53 Radiation Oncology ASTRO 53 Transcatheter Cardiovascular Therapeutics 53 Opportunistic Infections CROI 53 Gastrointestinal Cancer 53 Liver EASL 52 Cancer Res 52 Hematology ASH Annual Meeting 52 Oncology ASTRO 52 League Against Rheumatism 52 Digestive Disease Week 52 NSABP 52 ICAAC 52 SWOG 52 Neuro Oncology 52 EULAR 52 EuroPCR 52 Arch Intern Med 51 Hematology Annual Meeting 51 Radiation Therapy Oncology 51 Pharmacoeconomics 51 Clinical Microbiology 51 annual Transcatheter Cardiovascular 51 Arteriosclerosis Thrombosis 51 Urologic Oncology 51 BIOTECHNICA 51 Cellular Therapy 51 Liver Diseases AASLD 51 Pharmacoepidemiology 51 Molecular Targets 51 Oncogene 51 SEAMEO 51 Medical Oncology ESMO 51 Abstract Number 50 OneMedForum 50 ASCO 50 Ann Intern Med 50 Heart Failure Society 50 American Roentgen Ray 50 Bladder Cancer 50 #:#-# [035] 50 Phase Ib clinical 50 PROPEL 50 Clavis Pharma 50 Liver Transplantation 50 Antimicrobial Agents 50 AACR 50 Chemotherapy ICAAC 50 Neuropsychopharmacology 50 Metastatic Melanoma 49 Thoracic Oncology 49 ESOMAR 49 Gynecologic Oncology Group 49 San Antonio Breast Cancer 49 Respiratory Society 49 HER2 positive metastatic breast 49 Cardiovascular Diseases 49 adecatumumab 49 AVAX 49 American Thoracic Society 49 colloquia 49 BioFinance 49 Preclinical Development 49 JMP Securities Healthcare 49 Natalizumab 49 IUPAC 49 Plenary Session

Back to home page